Literature DB >> 33423190

Reversal of cisplatin sensitization and abrogation of cisplatin-enriched cancer stem cells in 5-8F nasopharyngeal carcinoma cell line through a suppression of Wnt/β-catenin-signaling pathway.

Sirorut Sinnung1, Tavan Janvilisri2, Pichamon Kiatwuthinon3.   

Abstract

Nasopharyngeal carcinoma (NPC) is one of the rare cancers in western countries but predominant in Southeast Asian countries including Thailand. One major cause for failure of NPC chemotherapeutic treatments is reportedly correlated with the elevation of cancer stem cell (CSC) fractions. Thus, this present study aims to investigate the effect of cisplatin (CDDP) treatment on the enrichment of cancer stem-like cells (CSCs) and its associated signaling pathway in EBV-negative NPC cells. Cisplatin-pretreated 5-8F NPC cells (5-8F CDDP) were first generated by treating the cells with 0.5 μM cisplatin for 48 h. After the instant treatment, 5-8F CDDP showed increased IC50 values, demonstrating a decrease in CDDP sensitization. Besides, the proportion of NPC cells with cancer stem-like phenotypes comprising side population (SP), key stemness-related gene expressions including SOX2, ALDH1, CD24 was significantly enhanced. Additionally, 5-8F CDDP displayed the upregulation of β-catenin gene, suggesting its association with the CSC-initiating mechanism. Furthermore, a tankyrase inhibitor for Wnt/β-catenin pathway, XAV939, substantially reduced CSCs and retrieved the cisplatin sensitivity in 5-8F CDDP. This confirms that the Wnt/β-catenin signaling is accountable for rising of the CSC population in EBV-negative NPC. Finally, the combined treatment of CDDP and XAV939 exhibited lower 5-8F CDDP cell viability compared to the treatment of CDDP alone, suggesting the reversal of cisplatin sensitization. In conclusion, the enhancement of CSCs in 5-8F NPC cells caused by the instant cisplatin treatment is initially mediated through the upregulation of β-catenin and activation of Wnt/β-catenin signaling pathway. As a result, a primary chemotherapeutic treatment with closely monitoring the targeted Wnt/β-catenin signaling pathway could potentially prevent the development of CSCs and improve the treatment efficiency in NPC.

Entities:  

Keywords:  Cancer stem cell; Cisplatin; Nasopharyngeal carcinoma; Tankyrase inhibitor; Wnt/β-catenin signaling

Mesh:

Substances:

Year:  2021        PMID: 33423190     DOI: 10.1007/s11010-020-04045-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

Review 1.  Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review.

Authors:  Wei-Hua Jia; Hai-De Qin
Journal:  Semin Cancer Biol       Date:  2012-01-30       Impact factor: 15.707

2.  SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.

Authors:  S-L Xie; S Fan; S-Y Zhang; W-X Chen; Q-X Li; G-K Pan; H-Q Zhang; W-W Wang; B Weng; Z Zhang; J-S Li; Z-Y Lin
Journal:  Int J Cancer       Date:  2017-11-06       Impact factor: 7.396

3.  β-Catenin is important for cancer stem cell generation and tumorigenic activity in nasopharyngeal carcinoma.

Authors:  Rui Jiang; Xiaoshuang Niu; Yuxiang Huang; Xiaosheng Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-04       Impact factor: 3.848

Review 4.  Nasopharyngeal carcinomas: an update.

Authors:  J-P Spano; P Busson; D Atlan; J Bourhis; J-P Pignon; C Esteban; J-P Armand
Journal:  Eur J Cancer       Date:  2003-10       Impact factor: 9.162

5.  Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.

Authors:  King Chi Chan; Lai Sheung Chan; Joseph Chok Yan Ip; Carman Lo; Timothy Tak Chun Yip; Roger Kai Cheong Ngan; Ricky Ngok Shun Wong; Kwok Wai Lo; Wai Tong Ng; Anne Wing Mui Lee; George Sai Wah Tsao; Michael Kahn; Maria Li Lung; Nai Ki Mak
Journal:  Sci Rep       Date:  2015-04-21       Impact factor: 4.379

6.  Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma.

Authors:  Yue Cheng; Arthur Kwok Leung Cheung; Josephine Mun Yee Ko; Yee Peng Phoon; Pui Man Chiu; Paulisally Hau Yi Lo; Marian L Waterman; Maria Li Lung
Journal:  BMC Cell Biol       Date:  2013-09-27       Impact factor: 4.241

Review 7.  Cancer stem-like cell: a novel target for nasopharyngeal carcinoma therapy.

Authors:  Pingpin Wei; Man Niu; Suming Pan; Yanhong Zhou; Cijun Shuai; Jing Wang; Shuping Peng; Guiyuan Li
Journal:  Stem Cell Res Ther       Date:  2014       Impact factor: 6.832

8.  Evaluation of stem-like side population cells in a recurrent nasopharyngeal carcinoma cell line.

Authors:  Susan Ling Ling Hoe; Lu Ping Tan; Juliana Jamal; Suat Cheng Peh; Ching Ching Ng; Wen Cai Zhang; Munirah Ahmad; Alan Soo Beng Khoo
Journal:  Cancer Cell Int       Date:  2014-10-09       Impact factor: 5.722

9.  CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.

Authors:  Samantha Wei-Man Lun; Siu Tim Cheung; Phyllis Fung Yi Cheung; Ka-Fai To; John Kong-Sang Woo; Kwong-Wai Choy; Chit Chow; Chartia Ching-Mei Cheung; Grace Tin-Yun Chung; Alice Suk-Hang Cheng; Chun-Wai Ko; Sai-Wah Tsao; Pierre Busson; Margaret Heung-Ling Ng; Kwok-Wai Lo
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

10.  CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation.

Authors:  Yao-An Shen; Chia-Yu Wang; Hui-Yen Chuang; John Jeng-Jong Hwang; Wei-Hsin Chi; Chih-Hung Shu; Ching-Yin Ho; Wing-Yin Li; Yann-Jang Chen
Journal:  Oncotarget       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.